SynthesisAnnals of family medicine

Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis.

George N Okoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.